Good Glycemic Outcomes Following Bariatric Surgery Among Patients With Type 2 Diabetes, Obesity, and Low-Titer GAD Antibodies.
Ruveena KaurDavid KimRichard CutfieldMichael BoothLindsay PlankRinki MurphyPublished in: Diabetes care (2020)
Low-titer GAD in patients with T2D and retained C-peptide should not be a deterrent for bariatric surgery when the principal aim is diabetes remission.